In his 2025 to 2026 term as American Academy of Allergy, Asthma & Immunology president, Frank S. Virant, MD, FAAAAI, plans to ...

Sanofi in partnership with Regeneron to present 24 abstracts across approved and investigational medicines at AAAAI Annual Meeting in San Diego: Paris Friday, February 7, 2025, 12 ...

Regardless of sociodemographic or clinical characteristics, children with food allergy face a significant psychosocial burden ...

Astria Therapeutics, Inc. (Nasdaq:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunologic diseases, today announced that it will present quality ...

A multi-institutional study has identified one of the allergens responsible for eosinophilic esophagitis (EoE), an inflammatory disease of the esophagus. This is the first time one of the allergens ...

According to a recent study published in Allergy Asthma & Clinical Immunology, smoking parents, especially a mother who ...

The global pediatric mask market share is expected to grow from USD 734.04 million in 2023 to USD 1,068.48 million by 2031, ...

The state’s top lawyer accused a British multinational drug company of “deceptive and unfair practices” that endangered lives and exploited American taxpayers.

Phenotyping children with asthma based on rhinoconjunctivitis symptoms shows that rhinoconjunctivitis may not always be allergy driven.

CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, /PRNewswire/ -- Harbour BioMed (HKEX: 02142, the 'Company'), a global ...